Recap: eFFECTOR Therapeutics Q1 Earnings

eFFECTOR Therapeutics EFTR reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:01 PM.

Here's what investors need to know about the announcement.

eFFECTOR Therapeutics missed estimated earnings by 71.43%, reporting an EPS of $-0.24 versus an estimate of $-0.14.

Revenue was down $0 from the same period last year.

Last quarter the company beat on EPS by $0.02 which was followed by a 3.41% drop in the share price the next day.

Here's a look at eFFECTOR Therapeutics's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	-0.24	-0.21	-3.83	-0.24
EPS Actual	-0.22	-0.23	-0.17	0.07
Revenue Estimate	660K	640K	520K	350K
Revenue Actual	674K	867K	2.01M	0

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for eFFECTOR Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar